Literature DB >> 6234360

Human helper T cell factor(s). IV. Demonstration of a human late-acting B cell differentiation factor acting on Staphylococcus aureus Cowan I-stimulated B cells.

T Hirano, T Teranishi, B Lin, K Onoue.   

Abstract

At least two distinct B cell stimulatory factors (BSF) were found to be involved in the differentiation of Staphylococcus aureus Cowan I (SAC)-stimulated human B cells to IgG-producing cells. A factor tentatively called B cell differentiation factor I (BCDF I) was found in one fraction, and a second factor, BCDF II was found in another fraction. The BCDF I fraction alone induces IgG-production in SAC-stimulated B cells, but the BCDF II fraction does not. The BCDF II fraction enhances IgG production in SAC-stimulated B cells in the presence of the BCDF I fraction. Studies concerning the time-course of the action of the BCDF II fraction revealed that it contains a late-acting differentiation factor that acts on B cells most effectively when it is added to the SAC-stimulated B cell culture after the addition of BCDF I fraction; it induces IgG plaque-forming cells within 1 day. The pI value of a late-acting BCDF was in the range of 5 to 6; this pI range is different from that of BCDF I but similar to that of BCDF II, which was shown in our previous studies to be able to induce IgG production in Epstein Barr Virus-transformed B lymphoblastoid cell lines. In addition, the m.w. of a late-acting BCDF were about 35,000 and 20,000, which are the same as those of BCDF II, and thus its identity with BCDF II was suggested.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234360

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  IgA specific helper factor (alpha HF) in human colostrum.

Authors:  H Shinmoto; H Kawakami; S Dosako; Y Sogo
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

2.  Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograft.

Authors:  H R Hubbell; H E Vargas; K L Tsujimoto; G D Gibson; E C Pequignot; R D Bigler; W A Carter; D R Strayer
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

3.  Quantitative analysis of interleukin-6 expression in porcine spleen cells and alveolar macrophages using real-time PCR.

Authors:  D Y Lee; Y W Cho; S G Kang; N R Shin; I S Choi; S J Shin; H S Yoo
Journal:  Vet Res Commun       Date:  2004-08       Impact factor: 2.459

4.  Interleukin-5 (IL-5) and IL-6 define two molecularly distinct pathways of B-cell differentiation.

Authors:  T D Randall; F E Lund; J W Brewer; C Aldridge; R Wall; R B Corley
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

5.  Inhibitory effect of locally produced and exogenous interleukin-6 on tumor growth in vivo.

Authors:  G J Dougherty; J D Thacker; R S Lavey; A Belldegrun; W H McBride
Journal:  Cancer Immunol Immunother       Date:  1994-05       Impact factor: 6.968

6.  Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.

Authors:  B K Finck; B Chan; D Wofsy
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

7.  Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).

Authors:  T Hirano; T Taga; N Nakano; K Yasukawa; S Kashiwamura; K Shimizu; K Nakajima; K H Pyun; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

8.  Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production.

Authors:  T Hirano; T Taga; K Yasukawa; K Nakajima; N Nakano; F Takatsuki; M Shimizu; A Murashima; S Tsunasawa; F Sakiyama
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

Review 9.  Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir.

Authors:  Toshio Hirano
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

10.  The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells.

Authors:  A Muraguchi; T Hirano; B Tang; T Matsuda; Y Horii; K Nakajima; T Kishimoto
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.